Morbidity and Mortality Weekly Report (MMWR)

March 29, 2013 / Vol. 62 / No. RR–3
Diagnosis and Management of Q Fever — United States, 2013: Recommendations from CDC and the Q Fever Working Group

Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii. Transmission occurs primarily through inhalation of aerosols from contaminated soil or animal waste. No licensed vaccine is available in the United States. This report provides the first national recommendations issued by CDC for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals. The guidelines address treatment of acute and chronic phases of Q fever illness in children, adults, and pregnant women, as well as management of occupational exposures.

December 14, 2012 / Vol. 61 / No. SS–9
Outbreaks of Acute Gastroenteritis Transmitted by Person-to-Person Contact — United States, 2009–2010

Approximately 179 million cases of acute gastroenteritis (AGE) occur in the United States each year, and outbreaks of AGE are a substantial public health problem. Although CDC has conducted national surveillance for waterborne and foodborne AGE outbreaks since 1971 and 1973, respectively, no national surveillance existed for AGE outbreaks resulting primarily from person-to-person transmission before implementation of the National Outbreak Reporting System (NORS) in 2009. During 2009–2010, a total of 2,259 person-to-person AGE outbreaks were reported in NORS from 42 states and the District of Columbia. These outbreaks resulted in 81,491 reported illnesses, 1,339 hospitalizations, and 136 deaths. Prevention and control of person-to-person AGE outbreaks depend primarily on appropriate hand hygiene and isolation of ill persons.

June 1, 2012 / Vol. 59 / No. 53
Summary of Notifiable Diseases — United States, 2010

Health-care providers in the United States are required to report certain infectious diseases to a specified state or local authority. A disease is designated as notifiable if timely information about individual cases is considered necessary for prevention and control of the disease. Each year, CDC publishes a summary of the cases of notifiable disease reported for the most recent year for which data is available. This report presents a summary of notifiable diseases for 2010.

May 17, 2013 / Vol. 62 / Supplement / No. 2
Mental Health Surveillance Among Children — United States, 2005–2011

This report summarizes information about ongoing federal surveillance systems that can provide estimates of the prevalence of mental disorders and indicators of mental health among children living in the United States and presents estimates of childhood mental disorders and indicators from these systems during 2005–2011. Attention-deficit/hyperactivity disorder (6.8%) was the most prevalent parent-reported current diagnosis among children aged 3–17 years, followed by behavioral or conduct problems (3.5%), anxiety (3.0%), depression (2.1%), autism spectrum disorders (1.1%), and Tourette syndrome (0.2% among children aged 6–17 years). An estimated 4.7% of adolescents aged 12–17 years reported an illicit drug use disorder in the past year, 4.2% had an alcohol abuse disorder in the past year, and 2.8% had cigarette dependence in the past month. The overall suicide rate for persons aged 10–19 years was 4.5 suicides per 100,000 persons in 2010. Approximately 8% of adolescents aged 12–17 years reported ≥14 mentally unhealthy days in the past month.

February 1, 2013 / Vol. 62
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 Years and Adults Aged 19 Years and Older — United States, 2013

Each year, recommendations for routine use of vaccines in children, adolescents, and adults in the United States are developed by the Advisory Committee on Immunization Practices (ACIP). This year, for the first time, recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older are being published together. Health-care providers are advised to use both the recommended schedules for children and adults in combination with their footnotes and not as stand-alones. For guidance on the use of all the vaccines in the schedules, including contraindications and precautions to use of a vaccine, providers are referred to the respective ACIP vaccine recommendations.